Nano-Sized Power Source for Implants & Medical Devices: an ATP-driven, Molecular Based Rotation Engine
The National Cancer Institute seeks CRADA partners to develop a
working model of a molecular-base rotation engine which is
constructed of two cylinders, one inner and one outer whose inner
surfaces are coated (more...)
(Full Text)
Molecular-Based Computing Device
Background:
NCI seeks partners to work with
the Laboratory of Experimental and Computational Biology to develop
a working prototype of this protein-based computer. This
collaboration is open for a multi-party collaboration where one
collaborator provides (more...)
(Full Text)
A Novel MRI RF Receiving Network Transformer for Parallel Imaging
The National Institute
of Neurological Disorders and Stroke (NINDS) of the
National Institutes of Health (NIH) seeks a
Cooperative Research and Development
Agreement (CRADA) Collaborator to work with
NINDS in the development, manufacture and
commercialization of (more...)
(Full Text)
Nanoscale Detection Macromolecules
Background:
The National Cancer Institute,
Center for Cancer Research Nanobiology Program seeks a research
partnership to develop devices that can be used to detect and/or
selectively modify biomolecules. Possible uses of the nanoprobes
include detection (more...)
(Full Text)
Intracellular RNA Sequencer
The National Cancer Institute, Center for Cancer Research Nanobiology Program seeks a research and development partner to develop a single molecule sequencing device.
The MedusaJ Sequencer consists of a DNA or (more...)
(Full Text)
Bioinformatic Tools for Genomic DNA Sequence Dimorphisms (Indels)
Background:
The National Cancer Institute,
Center for Cancer Research, Mouse Cancer Genetics Program is
seeking statements of capability or interest from parties
interested in collaborative research to further develop, evaluate,
or commercialize identification and use (more...)
(Full Text)
Biotinylated Alkylating Acridine for Pull-downs of Viral Pre-integration Complexes (PIC) or Other Cytosol Localized DNAs
(Full Text)
Antisera to Detect Phosphorylated Phosphoinositide-Dependent Kinase 1 (PDK-
Background:
The National Institutes of
Health, National Center for Complementary and Alternative Medicine,
Diabetes Unit is seeking statements of capability or interest from
parties interested in collaborative research to further develop,
evaluate, or commercialize phospho-specific (more...)
(Full Text)
Quantitative Determination of Marker Proteins in Complex Mixtures
Background:
The Laboratory of Neurotoxicology
of the National Institute of Mental Health and the Laboratory of
Cell Biology of the National Cancer Institute are seeking
statements of capability or interest from parties interested in
forming (more...)
(Full Text)
3-D Imaging and Mass Spectrometry of Mammalian Cells
Background:
The National Cancer Institute's
Cell Biology Laboratory is seeking statements of capability or
interest from parties interested in collaborative research and/or
partnership agreements to further develop and commercialize tools
for three-dimensional mapping of cells (more...)
(Full Text)
A New Technology for Identification of Hypoxia-Dependent Transcriptional Activation
Background:
The Screening Technologies Branch
of the National Cancer Institute is seeking statements of
capability or interest from parties interested in collaborative
research to obtain pre-clinical data to be used to further develop,
evaluate, or (more...)
(Full Text)
Imaging System for Correlative Electron/Confocal Fluorescence Microscopy
Background:
The National Cancer Institute's
Cell Biology Laboratory is seeking statements of interest or
capability from parties interested in collaborative research
agreements to further develop and commercialize a methodology and
device for the microscopic examination (more...)
(Full Text)
Human and Improved Murine Monoclonal Antibodies Against CD22
Background:
The National Cancer Institute's
Nanobiology Program is seeking statements of capability or interest
from parties interested in collaborative research to further
develop, evaluate, or commercialize human monoclonal antibodies
expressed in types of lymphoma.
CD22 is (more...)
(Full Text)
Carbon Nanotube Transistor -Based Microarray Binding Sensors
Background:
The National Cancer Institute's
Oncogenomics Section is seeking statements of capability or
interest from parties interested in collaborative research to
further develop, evaluate, or commercialize electronic detection of
nucleic acid and protein levels.
Description of
Technology:
This (more...)
(Full Text)
Optical Cells with Biological Applications
Background:
NICHD is seeking statements of
capability or interest from parties interested in collaborative
research and/or partnership agreements to develop, evaluate, or
commercialize optical cells with tissue pathology diagnostic
applications. Apart from pathology diagnostics, potential
applications (more...)
(Full Text)
Magnetic Resonance Imaging Method For Estimating Cone Of Uncertainty
Background:
The National Institute of Child Health and Human Development
(NICHD), Section on Tissue Biophysics and Biomimetics, is seeking
statements of capability or interest from parties interested in
collaborative research to further develop, evaluate, (more...)
(Full Text)
Methods To Treat Fatty Liver Disease
Transgenic Mouse Model For Development Of Cancer Therapeutics
Therapeutics Based On The Induced Internalization Of Surface Receptors
TTC maintains an e-mail service to notify you of new Collaborative Opportunities. If you would like to receive these emails, please sign up below. If you'd like to unsubscribe you can use this form as well.